• Studies suggest that the “rebound” of symptoms occurs in only a small number of patients.
• Experts say that while these cases need to be studied, Paxlovid is still a key treatment for COVID-19.
Some patients who have taken Pfizer Inc.’s oral antiviral Paxlovid are reporting that their COVID-19 symptoms returned after initially improving when they completed treatment.
Research suggests that this “rebound” occurs in a very small number of patients, with most people having mild or moderate symptoms upon their return.
More research is needed to confirm these results, but here’s what we know so far about this return of COVID-19 symptoms after Paxlovid treatment.
Release date :
2022/07/11
Code :
10032
Visits:
914